Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Respir Med ; 186: 106544, 2021 09.
Article in English | MEDLINE | ID: mdl-34325240

ABSTRACT

BACKGROUND: Esophageal atresia and tracheo-esophageal fistula (TEF), a well described congenital anomaly of the aero-digestive tract, commonly presents with inability to swallow and feed immediately after birth. However, diagnosis of recurrent or isolated TEF can be challenging and requires a combination of endoscopic and contrast studies. We describe a hitherto unreported technique of low flow intermittent oxygen insufflation into the suspicious tract and examine its safety and diagnostic yield for identification of occult TEF. METHODS: A retrospective single center cohort study, analyzing case notes of patients with TEF who underwent bronchoscopic oxygen insufflation for suspected recurrent or isolated TEF between 2006 and 2019 at a tertiary pediatric hospital. RESULTS: One-hundred and seven patients with TEF underwent 142 bronchoscopies during the study period. Of these, 22 patients underwent 28 bronchoscopies with oxygen insufflation. Twelve (43%) open fistulas were identified; of these, 9 (75%) were found using oxygen insufflation, revealing the fistula in 4/9 (44%) cases that had not been apparent using simple bronchoscopic visualization alone. One fistula was missed with multiple investigations, including bronchography and found only using oxygen insufflation. No complications were encountered. CONCLUSIONS: Recurrent or isolated TEF may be missed using ordinary flexible bronchoscopy and imaging studies. Low flow oxygen insufflation can be applied safely and may detect otherwise occult TEF.


Subject(s)
Bronchoscopy/methods , Insufflation/methods , Oxygen , Tracheoesophageal Fistula/diagnosis , Child , Female , Humans , Male , Pressure , Recurrence , Retrospective Studies , Safety
2.
Pediatrics ; 145(5)2020 05.
Article in English | MEDLINE | ID: mdl-32269136

ABSTRACT

Systemic sclerosis sine scleroderma (ssSSc) is a rare variant of systemic sclerosis, with only one pediatric case reported in the medical literature to date. Pulmonary arterial hypertension as the presenting feature of ssSSc is extremely rare, even in adults, and so far has never been reported in children. We report, for the first time, a case of pediatric ssSSc in a 3-year-old girl, who presented with interstitial lung disease and pulmonary hypertension. The patient was prescribed early aggressive pulmonary vasodilators combined with anti-inflammatory medications. The clinical response was good, and her current condition at 12 years of age is remarkable, considering the high mortality rates reported in adults. We underscore the importance of early aggressive treatment in future cases of similar presentation.


Subject(s)
Pulmonary Arterial Hypertension/complications , Pulmonary Arterial Hypertension/diagnostic imaging , Scleroderma, Systemic/complications , Scleroderma, Systemic/diagnostic imaging , Cardiac Catheterization/methods , Child , Child, Preschool , Female , Humans , Pulmonary Arterial Hypertension/therapy , Scleroderma, Systemic/therapy
3.
Clin Pediatr (Phila) ; 58(14): 1522-1527, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31556700

ABSTRACT

We examined the clinical and physiological benefits of heated humidified high-flow nasal cannula (HHHFNC) in treating pediatric bronchiolitis in a general pediatric ward. Children aged 0 to 2 years, hospitalized with moderate to severe bronchiolitis, were connected to HHHFNC. Each child was evaluated at 4- to 10-hour intervals, both on and off the device, using the Wang et al Bronchiolitis Severity score and transcutaneous CO2 monitor. Sixteen children were included in the final analysis. The Bronchiolitis Severity score improved by 3 points during the first and second intervals (P = .001). Transcutaneous CO2 values were reduced by an average 8.7 mm Hg (P = .001). No adverse effects were noted in children connected to the device. The HHHFNC device used in a general pediatric ward setting served as a safe and efficacious tool in treating moderate to severe bronchiolitis. Immediate clinical and physiological improvement was observed and maintained 1 to 4 hours after disconnection from the device.


Subject(s)
Bronchiolitis/physiopathology , Noninvasive Ventilation/methods , Oxygen Inhalation Therapy/methods , Administration, Intranasal , Bronchiolitis/therapy , Catheters , Child , Female , Hospitals, Pediatric , Humans , Infant , Infant, Newborn , Male , Treatment Outcome
4.
Pediatr Pulmonol ; 52(1): 77-83, 2017 01.
Article in English | MEDLINE | ID: mdl-27333438

ABSTRACT

OBJECTIVE: When bronchopulmonary dysplasia (BPD) is complicated by pulmonary hypertension (PH), morbidity and mortality are significantly increased. BPD-associated PH is not included in the current indications for PH medications. However, limited data demonstrate hemodynamic improvement and decreased mortality with PH-specific treatment. This report describes our 6-year experience treating BPD-associated PH with PH medications, mainly sildenafil. STUDY DESIGN: The medical records of 20 infants diagnosed with BPD-associated PH at a tertiary pediatric pulmonary hypertension clinic in 2008-2014 were reviewed. Clinical improvement was defined as a decrease in Ross functional class by at least one degree. PH severity was classified by echocardiography as mild, moderate, or severe. Hemodynamic improvement was defined as a decrease in PH severity by at least one level. RESULTS: Eighteen out of 20 patients were treated with PH medications: 12 sildenafil, 5 sildenafil and bosentan, and 1 bosentan. Median follow-up time was 2 years. Mean functional class significantly decreased from 3.2 ± 0.9 at diagnosis to 1.7 ± 0.9 at the last follow-up. Improvement in functional class was observed in 15/16 children (94%). Moderate or severe PH was found in 13/18 children (72%) at diagnosis, and in three (17%, all moderate PH) at the last follow-up. Improvement in PH class by echocardiography was demonstrated in 14/18 children (78%). The survival rate was 95%. CONCLUSION: Treatment of BPD complicated by PH with PH-specific medications, mainly sildenafil, is associated with improvement in both clinical and hemodynamic parameters and a low mortality rate. Pediatr Pulmonol. 2017;52:77-83. © 2016 Wiley Periodicals, Inc.


Subject(s)
Antihypertensive Agents/therapeutic use , Bronchopulmonary Dysplasia/complications , Hypertension, Pulmonary/drug therapy , Sildenafil Citrate/therapeutic use , Sulfonamides/therapeutic use , Antihypertensive Agents/pharmacology , Bosentan , Bronchopulmonary Dysplasia/diagnostic imaging , Child, Preschool , Drug Therapy, Combination , Echocardiography , Female , Hemodynamics/drug effects , Humans , Hypertension, Pulmonary/diagnostic imaging , Hypertension, Pulmonary/etiology , Infant , Infant, Newborn , Male , Retrospective Studies , Sildenafil Citrate/pharmacology , Sulfonamides/pharmacology , Treatment Outcome
5.
Clin Transplant ; 27(3): E289-94, 2013.
Article in English | MEDLINE | ID: mdl-23551332

ABSTRACT

Data, on the kinetic and serum levels of immunoglobulins in the immediate post-liver transplantation (LTx) period, are sparse with existing studies limited to adults or case reports of children. The aim of this study is to describe the phenomenon of hypogammaglobulinemia (HGG) in the immediate post-transplantation period among children undergoing LTx. A retrospective 10-yr chart review was conducted of all children who underwent LTx at a fourth-level pediatric medical center. Fifty-seven, of the 76 children who underwent LTx, were included in the study. Seventeen (29.8%) (mean age, 6.8 ± 5.2 yr) had HGG (11-IgG, 1-IgG+IgA, 1-IgG+IgM, 4-IgG+IgA+IgM), detected at 2 to 25 d after transplantation. Abdominal fluid was drained for 5 to 42 d; the amount drained until detection of HGG measured 27-668 mL/kg. HGG was associated with increased infection rate 0.9 episodes/patient vs. 0.17 episodes/patient (p < 0.01) in children without detected HGG. In conclusion, HGG is not rare in the immediate post-LTx period in children, and it may place patients at increased risk of infection. Further studies are needed to delineate the rate of occurrence, risk factors, and clinical implications of hypogammaglobulinemia in this patient population.


Subject(s)
Agammaglobulinemia/diagnosis , Liver Diseases/complications , Liver Transplantation/adverse effects , Adolescent , Adult , Agammaglobulinemia/etiology , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Liver Diseases/surgery , Male , Postoperative Complications , Prognosis , Retrospective Studies , Risk Factors , Time Factors
6.
Acta Paediatr ; 102(6): e263-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23421914

ABSTRACT

AIM: Viral pneumonia is a serious complication in immunocompromised children. Its aetiology is difficult to identify owing to the limitations of conventional microbiological tests. The aim of this study was to determine whether polymerase chain reaction (PCR) assays for respiratory viruses increase the diagnostic yield of bronchoalveolar lavage (BAL) in immunocompromised children. METHODS: BAL samples obtained from immunocompromised children hospitalized with pneumonia were processed for respiratory viruses by viral culture, rapid antigen test and PCR (for CMV, adenovirus, influenza, parainfluenza, herpesvirus, RSV and hMPV). RESULTS: The study group included 42 patients (mean age 7.2 ± 5.1 years) with 50 episodes of clinical pneumonia (50 BAL samples). Forty viral pathogens were identified in 30 episodes (60%). PCR increased the diagnostic rate by fourfold (75% identified by PCR alone, p < 0.0001). When viral culture and rapid antigen test were used as the gold standard, PCR was found to have high sensitivity (86-100% when assessed) and specificity (80-96%). The PCR results prompted the initiation of specific antiviral therapy and the avoidance of unnecessary antibiotic treatment in 17 (34%) episodes. CONCLUSION: PCR-based diagnosis from BAL may increase the rate of pathogen detection in immunocompromised children, decrease the time to diagnosis and spare patients unnecessary antimicrobial treatment.


Subject(s)
Bronchoalveolar Lavage , Immunocompromised Host , Pneumonia, Viral/diagnosis , Adolescent , Antigens, Viral/analysis , Child , Child, Preschool , Coinfection/epidemiology , Female , Humans , Infant , Male , Pneumonia, Viral/drug therapy , Pneumonia, Viral/epidemiology , Polymerase Chain Reaction , Retrospective Studies , Sensitivity and Specificity , Young Adult
7.
Pediatrics ; 130(1): e230-5, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22711721

ABSTRACT

Catastrophic antiphospholipid syndrome (APS) in pediatric medicine is rare. We report 3 adolescents who presented with acute onset of severe abdominal pain as the first manifestation of probable catastrophic APS. The 3 patients, 2 male patients and 1 female patient were 14 to 18 years old. One had been diagnosed with systemic lupus erythematosus in the past, but the other 2 had no previous relevant medical history. All presented with excruciating abdominal pain without additional symptoms. Physical examination was noncontributory. Laboratory results were remarkable for high inflammatory markers. Abdominal ultrasonography was normal, and abdominal computed tomography scan showed nonspecific findings of liver infiltration. Only computed tomography angiography revealed evidence of extensive multiorgan thrombosis. All patients had elevated titers of antiphospholipid antibodies. The patients were treated with full heparinization, high-dose steroids, and intravenous immunoglobulin with a resolution of symptoms. One patient was resistant to the treatment and was treated with rituximab. In conclusion, severe acute abdominal pain can be the first manifestation of a thromboembolic event owing to catastrophic APS even in previously healthy adolescents. Diagnosis requires a high index of suspicion with prompt evaluation and treatment to prevent severe morbidity and mortality.


Subject(s)
Abdomen, Acute/etiology , Antiphospholipid Syndrome/diagnosis , Adolescent , Antiphospholipid Syndrome/complications , Catastrophic Illness , Female , Humans , Male , Thrombosis/diagnosis , Thrombosis/etiology
8.
Pediatr Pulmonol ; 47(10): 994-1000, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22328487

ABSTRACT

OBJECTIVE: Fungal pneumonia is a serious complication in immunocompromised children. It is difficult to diagnose because of the low sensitivity of clinical and standard laboratory tests. The aim of this study was to investigate the diagnostic impact of polymerase chain reaction (PCR) assays for fungal pathogens in bronchoalveolar lavage (BAL) fluid. STUDY DESIGN: BAL samples obtained from hospitalized immunocompromised patients with clinical pneumonia between January 2007 and June 2009 were processed for microscopy and cultures in addition to PCR-based fungal assays. The results were compared between the standard and PCR methods. RESULTS: Seventy-seven children with 100 episodes of pneumonia were included in the study. Fungal pathogens were detected by standard microbiological investigations in 10 episodes (10%) and by PCR-based assays alone in 20 episodes (20%). There was no significant difference in clinical improvement or mortality rate between patients diagnosed by the different methods. In 61 episodes, no fungal pathogen was identified by either method. Prolonged antifungal therapy was avoided in 43 episodes. CONCLUSION: PCR-based assay for the diagnosis of fungal pulmonary infections may be a useful adjunct to clinical and standard microbiological techniques. The use of PCR may decrease the time to diagnosis, increase the rate of detection of fungal pathogens, and spare patients unnecessary antifungal treatment.


Subject(s)
Bronchoalveolar Lavage Fluid/microbiology , Immunocompromised Host , Lung Diseases, Fungal/diagnosis , Polymerase Chain Reaction/methods , Adolescent , Antifungal Agents/therapeutic use , Child , Child, Preschool , DNA, Fungal/analysis , Female , Fungi/isolation & purification , Humans , Infant , Lung Diseases, Fungal/drug therapy , Lung Diseases, Fungal/microbiology , Male , Pneumonia/diagnosis , Pneumonia/microbiology , Treatment Outcome , Young Adult
9.
J Pediatr Surg ; 46(4): 764-766, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21496552

ABSTRACT

Thrombotic thrombocytopenic purpura is caused by an imbalance of von Willebrand factor and its cleaving protease, which leads to the formation of microthrombi in end-organs. It rarely occurs in the pediatric population. Plasma exchange can significantly reduce mortality and morbidity. We present a 14-month-old infant in whom clinical and laboratory abnormalities compatible with thrombotic thrombocytopenic purpura were noted several days after resection of a large pelvic tumor. Treatment with double volume plasma exchange on postoperative day 5 led to complete resolution of the renal failure, thrombocytopenia, anemia, and neurological manifestations. ADAMTS13 inhibitors were negative and no mutations were found in factor H, factor I, membrane cofactor protein, and thrombomodulin to account for genetic predisposition to thrombotic thrombocytopenic purpura or atypical hemolytic uremic syndrome. Postoperative anemia, thrombocytopenia, fever, and neurological deficits in children should raise the suspicion of thrombotic thrombocytopenic purpura. Early diagnosis is important because the disorder is readily and efficiently treated with plasma exchange.


Subject(s)
Endodermal Sinus Tumor/surgery , Laparotomy/adverse effects , Pelvic Neoplasms/surgery , Plasma Exchange/methods , Plasmapheresis/methods , Purpura, Thrombotic Thrombocytopenic/etiology , von Willebrand Factor/metabolism , Female , Humans , Infant , Postoperative Complications , Purpura, Thrombotic Thrombocytopenic/blood , Purpura, Thrombotic Thrombocytopenic/therapy
10.
Acta Paediatr ; 100(2): 216-9, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20825601

ABSTRACT

AIM: To further characterize apnoea(s) complicating bronchiolitis because of respiratory syncytial virus (RSV), to describe the incidence of this complication and identify possible risk factors for apnoea(s) and its development. METHODS: The files of infants admitted to the paediatric intensive care unit (PICU) for RSV bronchiolitis during three bronchiolitis seasons (2004-2007) were reviewed for demographic, clinical and laboratory parameters. Parameters were compared between patients with and without apnoeas. RESULTS: Seventy-nine patients met the study criteria: 43 were admitted to the PICU for central apnoeas and the remainder for respiratory distress or failure. The percentage of infants admitted for apnoea increased during the study period (28.6 to 77.1%, p = 0.004). The overall prevalence of apnoea in this population was 4.3%. Possible risk factors for apnoea(s) were younger age (1.3 vs. 4.3 months, p = 0.002), lower admission weight (3.3 vs. 5 kg, p < 0.001), lower gestational age (35.8 vs. 37.8 weeks, p = 0.01), admission from the emergency room (50% vs. 9.1%, p < 0.001) and lack of hyperthermia (p < 0.001). Respiratory acidosis was found to be a protective factor on logistic regression analysis. CONCLUSION: The prevalence of apnoea in infants admitted to the PICU for RSV bronchiolitis in our centre may be increasing. Preterm, younger infants with no fever are at relatively high risk of apnoea at presentation, while older infants with fever are at lower risk.


Subject(s)
Bronchiolitis/complications , Sleep Apnea, Central/etiology , Humans , Incidence , Infant , Intensive Care Units, Pediatric , Retrospective Studies , Risk Factors , Sleep Apnea, Central/epidemiology
11.
Pediatr Transplant ; 15(7): E130-4, 2011 Nov.
Article in English | MEDLINE | ID: mdl-20408994

ABSTRACT

HPS is rare in the pediatric population. Liver transplantation is the ultimate treatment for severe HPS. There are only a few case reports and one series of children in whom HPS was the main indication for liver transplantation. Outcome was good in most of them, with full regression of the pulmonary process. However, hypoxemia in the early post-operative course can have severe consequences, and effective treatment modalities are needed. There are rare instances of the use of iNO for the treatment of post-operative hypoxemia. We describe a 10.5-yr-old boy with severe HPS owing to chronic liver disease after bone marrow transplantation. Liver transplantation from a living related donor (the same sister who donated the bone marrow) was complicated by severe hypoxemia on POD 2. iNO was administered via the ventilator circuit and, after extubation, through nasal prongs. It was slowly tapered down and stopped on POD 10. The child had an otherwise uneventful course and was discharged home on POD 21 with normal oxygen saturation. Liver transplantation should be offered to children with severe HPS. iNO can reverse the hypoxemia that may occur after the operation.


Subject(s)
Hepatopulmonary Syndrome/therapy , Liver Transplantation/methods , Nitric Oxide/metabolism , Angiography/methods , Bone Marrow Transplantation/adverse effects , Child , Echocardiography/methods , End Stage Liver Disease/complications , Humans , Hyperplasia/pathology , Hypoxia/complications , Hypoxia/metabolism , Hypoxia/pathology , Lung/pathology , Male , Oxygen/chemistry , Postoperative Period , Tomography, X-Ray Computed/methods , Treatment Outcome
12.
J Intensive Care Med ; 24(6): 383-8, 2009.
Article in English | MEDLINE | ID: mdl-19875390

ABSTRACT

The aim of the study was to describe our experience with bi-level positive airway pressure (BiPAP) ventilation in oncology children with acute respiratory failure, hospitalized in a single tertiary pediatric tertiary center. This was a retrospective cohort study of all pediatric oncology patients in our center admitted to the intensive care unit with acute hypoxemic or hypercarbic respiratory failure from January 1999 through May 2006, who required mechanical ventilation with BiPAP. Fourteen patients met the inclusion criteria with a total of 16 events of respiratory failure or impending failure: 12 events were hypoxemic, 1 was combined hypercarbic and hypoxemic, and 3 had severe respiratory distress. Shortly after BiPAP ventilation initiation, there was a statistically significant improvement in the respiratory rate (40.4 +/- 9.3 to 32.5 +/- 10.1, P < .05] and a trend toward improvement in arterial partial pressure of oxygen (PaO(2); 71.3 +/- 32.7 to 104.6 +/- 45.6, P = .055). The improvement in the respiratory status was sustained for at least 12 hours. In 12 (75%) events there was a need for sedation during ventilation; 12 children needed inotropic support during the BiPAP ventilation. Bi-level positive airway pressure ventilation failed in 3 (21%) children who were switched to conventional ventilation. All of them have died during the following days. One child was recategorized to receive palliative care while on BiPAP ventilator and was not intubated. In 12 of 16 BiPAP interventions (75%; 11 patients), the children survived to pediatric intensive care unit (PICU) discharge without invasive ventilation. No major complications were noted during BiPAP ventilation. Bi-level positive airway pressure ventilation is well tolerated in pediatric oncology patients suffering from acute respiratory failure and may offer noninferior outcomes compared with those previously described for conventional invasive ventilation. It appears to be a feasible initial option in children with malignancy experiencing acute respiratory failure.


Subject(s)
Neoplasms/physiopathology , Positive-Pressure Respiration/methods , Respiratory Insufficiency/physiopathology , Respiratory Insufficiency/therapy , Acute Disease , Adolescent , Child , Child, Preschool , Female , Humans , Intensive Care Units, Pediatric , Male , Neoplasms/mortality , Positive-Pressure Respiration/mortality , Respiratory Insufficiency/mortality , Retrospective Studies , Statistics, Nonparametric , Treatment Outcome , Young Adult
13.
Zhonghua Er Ke Za Zhi ; 47(2): 87-90, 2009 Feb.
Article in Chinese | MEDLINE | ID: mdl-19573450

ABSTRACT

OBJECTIVE: To investigate etiology and airway management in children with tracheobronchomalacia. METHOD: Bronchoscopic examinations were performed in 671 children. The cases with tracheomalacia and bronchomalacia were analyzed in etiopathogenesis and summarized their therapy simultaneously. RESULT: Bronchoscopic examination indicated tracheomalacia and bronchomalacia in 148 cases, tracheomalacia in 77 cases and bronchomalacia in 71 cases. Among the cases with tracheomalacia, compression by vascular rings was found in 46 cases, incorporated congenital esophageal atresia with tracheoesophageal fistula was found in 5 cases, tracheomalacia was associated with tracheostoma and mechanical ventilation in 6 cases, with congenital airway malformation in 11 cases and isolated tracheomalacia was found in 4 cases. Among the cases with bronchomalacia, incorporated congenital cardiovascular malformation was found in 64 cases, congenital airway malformation in 6 cases and isolated bronchomalacia in 1 case. Ten children with anomalous innominate artery underwent aortopexy, twelve children with dextro-aorta arch with concomitant aberrant left subclavian artery and double aorta underwent arches vascular ring lysis, six children with pulmonary sling underwent plasty. Severe malacia segments were resected directly in four children during operation. Mechanical ventilation was performed in 38 children. Tracheostoma was performed in 4 children to treat tracheomalacia and bronchomalacia, it could relieve symptom to a certain extent. In 2 children metal stents were inserted into the bronchus for the treatment of bronchomalacia, one was successful and the other needed re-insertion of stent again, these two patients underwent balloon-dilatation in distal part of stent afterwards. CONCLUSION: The congenital cardiovascular malformation was the main reason to develop tracheobronchomalacia in children. The symptom of majority of the cases with cardiovascular malformation would be improved within 6 months after surgical intervention. In severe cases, treatments included mechanical ventilation and tracheostoma. Stenting could be applied in refractory cases, but it had certain limitations.


Subject(s)
Heart Defects, Congenital/complications , Trachea/pathology , Tracheobronchomalacia/etiology , Child , Child, Preschool , Female , Heart Defects, Congenital/therapy , Humans , Infant , Male , Stents , Tracheal Stenosis/etiology , Tracheal Stenosis/therapy , Tracheobronchomalacia/diagnosis , Tracheobronchomalacia/therapy
14.
Ann Otol Rhinol Laryngol ; 117(11): 839-43, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19102130

ABSTRACT

OBJECTIVES: Foreign body aspiration (FBA) is a life-threatening event in children. The gold standard for diagnosis is bronchoscopy, but there is no consensus regarding indications for the procedure. The aim of this study was to formulate a predictive model for assessing the probability of FBA in suspected cases as an aid in the decision to perform diagnostic bronchoscopy. METHODS: The files of 150 patients who underwent bronchoscopy for suspected FBA at our center between 1996 and 2004 were reviewed for medical history, physical examination, and radiologic studies. The findings were analyzed by logistic regression. RESULTS: Using the file data, we formulated a predictive model wherein each parameter received a numeric coefficient representing its significance in evaluating suspected FBA. The most significant parameters were age 10 to 24 months, foreign body in the child's mouth and severe respiratory complaints during the choking episode, hypoxemia, dyspnea or stridor following the acute event, unilateral signs on lung auscultation, abnormal tracheal radiogram, unilateral infiltrate or atelectasis, and local hyperinflation or obstructive emphysema on chest radiogram. CONCLUSIONS: In our predictive model, every case of suspected FBA can be assigned a score based on the specific parameters present, which is then entered into a probability formula to determine the likelihood of a positive diagnosis. This model may serve as a useful tool for deciding on the use of bronchoscopy in all children with suspected FBA.


Subject(s)
Airway Obstruction/diagnosis , Bronchi , Diagnosis, Computer-Assisted/instrumentation , Foreign Bodies/diagnosis , Airway Obstruction/etiology , Algorithms , Bronchoscopy , Child, Preschool , Diagnosis, Differential , Equipment Design , Female , Follow-Up Studies , Foreign Bodies/complications , Humans , Infant , Male , Predictive Value of Tests , Retrospective Studies
15.
Pediatr Crit Care Med ; 7(2): 115-8, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16474259

ABSTRACT

OBJECTIVES: To determine the efficacy of oral amphotericin B for the prevention of Candida bloodstream infection in the pediatric intensive care unit. DESIGN: Retrospective, nonrandomized, historic-control study. SETTING: Multidisciplinary pediatric intensive care unit at a university-affiliated children's medical center. PATIENTS: Study group included all patients admitted to the pediatric intensive care unit from January 1, 1998, to December 31, 1999, who required mechanical ventilation and who were admitted for >7 days. The control group included all patients admitted for >7 days who needed mechanical ventilation from January 1, 1994, to December 31, 1997. INTERVENTIONS: Oral amphotericin B suspension, 50 mg every 8 hrs, administered to all study group patients soon after initiation of mechanical ventilation and terminating after weaning. MEASUREMENTS: The rates of Candida bloodstream infection were compared between the study and control groups. MAIN RESULTS: Candida species were isolated from blood cultures in 5 of 185 (2.1%) and 21 of 196 (10.7%) patients in the study and control groups, respectively (p= .0038). There was also a statistically significant (p= .017) decrease in Candida bloodstream infection rate in all patients admitted to the pediatric intensive care unit for >7 days during the study period compared with the Candida bloodstream infection rate during the control period. CONCLUSION: Prophylactic administration of oral amphotericin B may lead to a significant decrease in the rate of Candida bloodstream infection in ventilated pediatric intensive care unit patients.


Subject(s)
Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Candidiasis/prevention & control , Fungemia/prevention & control , Intensive Care Units, Pediatric , Administration, Oral , Amphotericin B/administration & dosage , Antifungal Agents/administration & dosage , Child , Critical Illness , Cross Infection/prevention & control , Humans , Respiration, Artificial , Retrospective Studies
16.
Chest ; 128(4): 2765-71, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16236953

ABSTRACT

STUDY OBJECTIVES: To assess the effect of palivizumab licensing for respiratory syncytial virus (RSV) prophylaxis on national pediatric ICU (PICU) admissions and on the need for mechanical ventilation due to RSV bronchiolitis in Israel. DESIGN: Prospective national surveillance survey. SETTING: All PICUs in Israel. PATIENTS OR PARTICIPANTS: All patients admitted to a PICU because of acute bronchiolitis in two consecutive RSV seasons (November 2000 to April 2001 and November 2001 to April 2002). METHODS: Data on demographic and epidemiologic factors and RSV prophylaxis status were collected for every infant with bronchiolitis who was admitted to a PICU in Israel in the year before and after issuance of the Israel Ministry of Health recommendation for palivizumab prophylaxis (January 2001). RESULTS: One hundred five patients were admitted to a PICU because of RSV bronchiolitis in the year before the recommendations were issued, and 123 patients were admitted in the year after they were issued. Mechanical ventilation was required by 33 and 42 children, respectively. Gestational age was > 32 weeks in 92.9% and 83.9% of the admitted patients, respectively, and 89% and 91% of the patients, respectively, were free of chronic lung disease (CLD). In both periods, 83% of the children who were admitted to a PICU did not meet the American Academy of Pediatrics criteria for RSV prophylaxis. CONCLUSIONS: Most of the children with severe RSV bronchiolitis needing PICU admission from 2000 to 2002 born at term did not have CLD and were not candidates for RSV prophylaxis according to the current recommendations.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antiviral Agents/therapeutic use , Bronchiolitis/virology , Respiratory Syncytial Virus Infections/drug therapy , Antibodies, Monoclonal, Humanized , Birth Weight , Bronchiolitis/drug therapy , Child , Gestational Age , Humans , Infant , Intensive Care Units, Pediatric , Israel , Palivizumab , Respiratory Syncytial Virus Infections/epidemiology , Seasons
17.
Pediatr Emerg Care ; 21(7): 427-30, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16027574

ABSTRACT

OBJECTIVES: To investigate the management of children with life-threatening airway obstruction from large mediastinal masses. METHODS: Review of the medical records of children with mediastinal masses and severe airway obstruction who were admitted to a multidisciplinary pediatric intensive care unit. RESULTS: Eight patients with 12 life-threatening events were identified. Five events (in 4 patients) occurred before hospital admission, and 3 patients had more than 1 choking episode. Five patients underwent cardiorespiratory resuscitation (2 before admission), and 2 underwent emergency endotracheal intubation because of severe airway obstruction; the eighth patient could not be weaned off the ventilator until the mediastinal mass was resected. Median time from appearance of the initial symptoms to diagnosis was 8.5 days, and median time from the onset of alarming signs to admission was 2 days. CONCLUSIONS: Severe airway obstruction in children with an anterior mediastinal mass is not rare and can lead to complete obstruction, requiring cardiorespiratory resuscitation. Physician awareness and preparedness for respiratory complications are essential for proper management of children with mediastinal masses.


Subject(s)
Airway Obstruction/etiology , Airway Obstruction/prevention & control , Mediastinal Neoplasms/complications , Pediatrics/methods , Bronchoscopy , Burkitt Lymphoma/complications , Burkitt Lymphoma/pathology , Burkitt Lymphoma/surgery , Cardiopulmonary Resuscitation , Child , Child, Preschool , Emergency Medical Services/methods , Female , Humans , Intubation, Intratracheal , Lymphoma, T-Cell/complications , Lymphoma, T-Cell/pathology , Lymphoma, T-Cell/surgery , Male , Mediastinal Neoplasms/pathology , Mediastinal Neoplasms/surgery , Respiration, Artificial , Thyroiditis, Suppurative/complications , Thyroiditis, Suppurative/pathology , Thyroiditis, Suppurative/surgery , Treatment Outcome
18.
J Intensive Care Med ; 19(1): 38-43, 2004.
Article in English | MEDLINE | ID: mdl-15035753

ABSTRACT

The objective of this study was to define current blood transfusion practices among European pediatric intensive care physicians treating critically ill children. A questionnaire of case scenarios was administered to members of the European Society of Pediatric and Neonatal Intensive Care (ESPNIC). Of the 258 members of the ESPNIC, 134 (51.9%) pediatric intensive care physicians completed the questionnaire. The suggested blood transfusion thresholds for case scenario 1 (post-orthopedic surgery child) ranged from <7.0 g/dl to 11 g/dl. A total of 57.3% suggested 7 g/dl, 33.6% suggested 8 g/dl, and 6.9% suggested 9 g/dl as a hemoglobin threshold for transfusion (mean, 7.54 +/- 0.75). For case scenarios 2 to 4, the suggested hemoglobin thresholds were 7 g/dl to 12 g/dl. For case scenario 2 (a child with acute respiratory distress syndrome), 22.4% suggested 8 g/dl, 15.7% suggested 9 g/dl, and 41% suggested 10 g/dl as a hemoglobin threshold for transfusion (mean, 9.40 +/- 1.27 g/dl). For case scenario 3 (a post-cardiac surgery infant), 20.1% suggested 7 g/dl, 24.6% suggested 8 g/dl, 21.6% suggested 9 g/dl, and 23.9% suggested 10 g/dl as a hemoglobin threshold for transfusion (mean, 8.72 +/- 1.24 g/dl). For case scenario 4 (a child with septic shock), 23.1% suggested 8 g/dl, 16.4% suggested 9 g/dl, and 41% suggested 10 g/dl as a hemoglobin threshold for transfusion (mean, 9.45 +/- 1.24 g/dl). The threshold for transfusion was not statistically different (P >.05) between the physicians according to their subspecialty, years of experience, or country of origin. The suggested volume of transfused blood was 10 to 15 ml/kg in 427 responses (82.6%) and 20 ml/kg in 89 responses (17.2%). Most physicians, 78/128 (60.9%), did not consider the age of the transfused blood an important factor in their decision to transfuse. Of the 106 (79.1%) physicians who detailed their considerations for elevating the threshold for transfusion, 82 (77.3%) gave a general nonspecific indication, 47 (44.3%) stated hemodynamic instability and shock, and 40 (37.7%) an ongoing bleeding. The hemoglobin threshold for blood transfusion and transfusion volume varies among European pediatric intensive care physicians, for the same patient.


Subject(s)
Blood Transfusion/standards , Intensive Care Units, Pediatric/standards , Patient Selection , Practice Patterns, Physicians'/statistics & numerical data , Analysis of Variance , Blood Transfusion/statistics & numerical data , Child , Child, Preschool , Critical Care/methods , Critical Care/standards , Europe , Health Care Surveys , Humans , Infant , Infant, Newborn , Intensive Care Units, Neonatal/standards
19.
Pediatrics ; 112(3 Pt 1): 548-52, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12949282

ABSTRACT

OBJECTIVE: Preterm infants, especially those with chronic lung disease (CLD), are considered more susceptible to severe respiratory illness from respiratory syncytial virus (RSV) infection than healthy term infants, and are therefore targeted for prophylactic administration of immune globulins. The impact of this practice on the more severe cases of bronchiolitis (i.e., pediatric intensive care unit [PICU] admission, mechanical ventilation, mortality) has not been reported to date. The aim of this study was to evaluate PICU admissions, need for mechanical ventilation, and mortality attributable to RSV bronchiolitis in Israel before the introduction of RSV prophylaxis to the country. DESIGN AND SETTING: Prospective survey of 11 PICUs in Israel during the RSV season (November 2000-March 2001). PATIENTS: All patients admitted to the PICU because of bronchiolitis, and the subgroups who needed mechanical ventilation or who died, were analyzed for known risk factors, namely, prematurity, CLD, and chronic oxygen dependence. RESULTS: A total of 105 patients with RSV bronchiolitis met the inclusion criteria, of whom 33 were mechanically ventilated. Most of the patients (84% total admission, 88% ventilated) were born after 32 weeks' gestation, and 89% and 88%, respectively, did not have CLD. Only 16% and 9%, respectively, met any of the American Academy of Pediatrics criteria for RSV prophylaxis, such that 84% of the whole sample and 91% of the ventilated patients were not candidates for RSV prophylaxis. Five patients died, 2 of them with cyanotic heart disease. CONCLUSIONS: Most of the infants with severe RSV bronchiolitis were born at term and did not have CLD. The great majority of patients admitted to the PICU for bronchiolitis were not candidates for RSV prophylaxis. Administration of RSV prophylaxis to the predefined high-risk population could be expected to yield no significant change in PICU admissions or number of infants needing mechanical ventilation. New risk-stratified guidelines for RSV prophylaxis are needed.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Bronchiolitis, Viral/epidemiology , Bronchiolitis, Viral/prevention & control , Health Care Surveys/methods , Intensive Care Units, Neonatal , Respiratory Syncytial Virus Infections/prevention & control , Antibodies, Monoclonal, Humanized , Antiviral Agents/therapeutic use , Bronchiolitis, Viral/mortality , Databases, Factual , Gestational Age , Heart Defects, Congenital/complications , Heart Defects, Congenital/epidemiology , Humans , Infant , Infant, Newborn , Infant, Premature , Intensive Care Units, Neonatal/statistics & numerical data , Israel/epidemiology , Palivizumab , Prospective Studies , Pulmonary Disease, Chronic Obstructive/epidemiology , Respiration, Artificial/statistics & numerical data , Respiratory Syncytial Virus Infections/epidemiology , Respiratory Syncytial Virus Infections/mortality , Surveys and Questionnaires
20.
Ann Thorac Surg ; 76(2): 601-3, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12902113

ABSTRACT

Inflammatory myofibroblastic tumor is a rare solid tumor that most often affects children and young adults. Although benign, the tumor may be very aggressive locally. We describe a 9-year-old boy with primary inflammatory myofibroblastic tumor of the left upper lobe involving the left atrium.


Subject(s)
Heart Atria/pathology , Plasma Cell Granuloma, Pulmonary/pathology , Plasma Cell Granuloma, Pulmonary/surgery , Biopsy, Needle , Cardiac Surgical Procedures/methods , Child , Follow-Up Studies , Heart Atria/surgery , Humans , Immunohistochemistry , Male , Pneumonectomy/methods , Rare Diseases , Risk Assessment , Severity of Illness Index , Thoracotomy/methods , Tomography, X-Ray Computed , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...